NEW YORK, NY / ACCESSWIRE / January 21, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Trans-Pacific Aerospace Company Inc. (OTC: TPAC), Rubicon Minerals Corp. (OTC: RBYCF), Cellceutix Corp. (OTC: CTIX) and CytoDyn Inc. (OTC: CYDY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
TPAC Research Package: http://www.traders-choice.com/pdf?s=TPAC
RBYCF Research Package: http://www.traders-choice.com/pdf?s=RBYCF
CTIX Research Package: http://www.traders-choice.com/pdf?s=CTIX
CYDY Research Package: http://www.traders-choice.com/pdf?s=CYDY
============
Highlights from today's reports include:
On Wednesday, January 20, 2016, Nasdaq Composite ended at 4,471.69, down 0.12%, Dow Jones Industrial Average declined 1.56%, to finish the day at 15,766.74, and the S&P closed at 1,859.33, down 1.17%.
- Trans-Pacific Aerospace Company Inc.'s stock edged lower by 10.26% to close Wednesday's session at USD 0.0035. The company's shares oscillated between USD 0.0033 and USD 0.0047. The stock recorded a trading volume of 45.74 million shares, which was below its 50-day daily average volume of 63.72 million shares and its 52-week average volume of 83.57 million shares. Over the last three days Trans-Pacific Aerospace Company Inc.'s shares have advanced 6.06% and in the past one week the stock has moved up 35.14%. Furthermore, over the last three months the stock has gained 775.00% and in the past six months the shares have picked up 600.00%. On a compounded total return basis, the company shares have returned 16.67% in the past one year. Moreover, the stock is having a 52-week range of USD 0.0001 – USD 0.0069.
- Rubicon Minerals Corp.'s stock edged lower by 12.82% to close Wednesday's session at USD 0.017. The company's shares oscillated between USD 0.016 and USD 0.021. The stock recorded a trading volume of 2.02 million shares, which was below its 50-day daily average volume of 3.39 million shares but above its 52-week average volume of 1.59 million shares. Over the last three days Rubicon Minerals Corp.'s shares have advanced 19.21% while in the past one week the stock has moved down 15.00%. Furthermore, over the last three months the stock has lost 96.40% and in the past six months the shares have shed 97.90%. Further, the stock is trading at a price to book ratio of 0.10, compared to its historical PB ratio of 2.42. Additionally, Rubicon Minerals Corp. is trading below its 50-day and 200-day moving averages of USD 0.08 and USD 0.49, respectively.
- Cellceutix Corp.'s stock edged lower by 9.57% to close Wednesday's session at USD 1.04. The company's shares oscillated between USD 1.01 and USD 1.16. The stock recorded a trading volume of 0.35 million shares, which was above its 50-day daily average volume of 0.25 million shares and its 52-week average volume of 0.29 million shares. Over the last three days Cellceutix Corp.'s shares have declined by 14.05% and in the past one week the stock has moved down 11.11%. Furthermore, over the last three months the stock has lost 14.75% and in the past six months the shares have shed 68.21%. Further, the stock is trading at a price to book ratio of 22.58, compared to its historical PB ratio of 43.26. Additionally, Cellceutix Corp. is trading below its 50-day and 200-day moving averages of USD 1.38 and USD 1.76, respectively. Moreover, the stock is having a 52-week range of USD 0.94 - USD 4.40.
- CytoDyn Inc.'s stock edged higher by 1.56% to close Wednesday's session at USD 0.88. The company's shares oscillated between USD 0.86 and USD 0.88. The stock recorded a trading volume of 0.07 million shares, which was at par with its 50-day daily average volume but slightly below its 52-week average volume of 0.08 million shares. Over the last three days CytoDyn Inc.'s shares have advanced 8.46% and in the past one week the stock has moved up 6.48%. However, over the last three months the stock has lost 0.73% and in the past six months the shares have shed 9.42%. Further, CytoDyn Inc. is trading above its 50-day and 200-day moving averages of USD 0.80 and USD 0.83, respectively. Moreover, the stock is having a 52-week range of USD 0.63 - USD 1.09.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice
